Natco Pharma Ltd will purchase equity shares in Time Cap Overseas Limited, Mauritius, a subsidiary of the company, from the other shareholder Venkatachari Madhusudhan who holds 6.10 per cent shares of the company.
This amounts to 72,710 equity shares of $10 face value amounting to $7,27,100. Following the acquisition, Time Cap Overseas will become a wholly-owned subsidiary of Hyderabad-based Natco Pharma. The transaction will be in cash.
The board had also allotted 1,18,360 equity shares of face value of ₹2 each to eligible employees under the fifth tranche, who had exercised their vested options under the Natco Employee Stock Option Scheme 2015.
These equity shares shall rank pari-passu with the existing equity shares of the company in all respects. In the NATSOP 2015 scheme, the balance of 54,405 equity shares were forfeited. With the above allotment, the NATSOP 2015 scheme has been completed and closed, the company informed the BSE.
Shares of Natco Pharma traded at ₹777.05 at noon, up 2.02 per cent from Wednesday’s closing on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.